ALLMedicine™ Sinus Bradycardia Center
Research & Reviews 308 results
https://doi.org/10.1186/s12864-022-09097-0
BMC Genomics; Wei SJ, Du JL et. al.
Feb 2nd, 2023 - To explore the causes of sudden unexpected death (SUD) and to search for high-risk people, whole exome sequencing (WES) was performed in families with SUDs. METHODS: Whole exome sequencing of 25 people from 14 SUD families were screened based on ...
https://doi.org/10.1017/S1047951123000100
Cardiology in the Young; Avcu G, Arslan A et. al.
Jan 24th, 2023 - Cardiac manifestations of the coronavirus disease 2019 (COVID-19) have mainly been reported in adults. Therefore, we aimed to determine the electrocardiographic abnormalities in hospitalised paediatric patients with COVID-19 and multisystemic infl...
https://clinicaltrials.gov/ct2/show/NCT05694585
Jan 23rd, 2023 - Airway intervention is known to activate stress response and release catecholamines resulting in severe hemodynamic instability. Various techniques which are recommended to prevent the stress response include increasing the depth of anesthesia, im...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750526
Medicine Yang F, Liu P et. al.
Jan 11th, 2023 - To investigate the mechanism of action of Datura metel in the treatment of sinus bradycardia based on network pharmacology and molecular docking. The active ingredients and targets of Datura metel were collected by TCMSP database, and the Cytoscap...
https://doi.org/10.3390/ijerph20010009
International Journal of Environmental Research and Publi... Wang Y, Chen Z et. al.
Jan 9th, 2023 - To process and extract electrocardiogram (ECG, ECG, or EKG) features using a convolutional neural network (CNN) to establish an ECG-assisted diagnosis model. Coal workers who underwent physical examinations at Gequan Mine Hospital and Dongpang Min...
Drugs 41 results see all →
Clinicaltrials.gov 22 results
https://clinicaltrials.gov/ct2/show/NCT05694585
Jan 23rd, 2023 - Airway intervention is known to activate stress response and release catecholamines resulting in severe hemodynamic instability. Various techniques which are recommended to prevent the stress response include increasing the depth of anesthesia, im...
https://clinicaltrials.gov/ct2/show/NCT02781207
Nov 3rd, 2022 - This is a observational prospective study. For patients presenting to the Emergency Department with loss of consciousness, emergency physicians will be asked to screen the real syncope without an evident and immediate cause for the loss of conscio...
https://clinicaltrials.gov/ct2/show/NCT05574855
Oct 12th, 2022 - Impact of hypoxia on the cardiovascular system Transitory hypoxia of the myocardium (and its resultant dysfunction), which may, but not necessarily, present clinically, occurs in two thirds of neonates born with perinatal asphyxia. There is no dou...
https://clinicaltrials.gov/ct2/show/NCT05408000
Jun 7th, 2022 - Electroconvulsive therapy (ECT) is a common treatment method used in severe depression and other psychiatric diseases. Currently, most ECT procedures are carried out with muscle paralysis under general anesthesia. It is important to establish an a...
https://clinicaltrials.gov/ct2/show/NCT04548973
Jan 27th, 2022 - case selection: A total of 600 patients (American Society of Anesthesiologists (ASA) grade I-II, aged 20-40 years,BMI 18.5-27) who underwent elective cesarean section were selected. anesthesia methods: All patients were not given preoperative medi...
News 52 results
https://www.medscape.com/viewarticle/985560
Dec 14th, 2022 - SAN ANTONIO — Updated results with the investigational oral selective estrogen receptor degrader (SERD) elacestrant give a hint of where it could find a place in the treatment paradigm for estrogen receptor positive (ER+) and HER2- advanced or met...
https://www.onclive.com/view/nab-paclitaxel-plus-pembrolizumab-produces-promising-responses-in-advanced-urothelial-cancer
May 2nd, 2022 - The combination of nab-paclitaxel (Abraxane) and pembrolizumab (Keytruda) produced an encouraging overall response rate (ORR) with manageable safety in patients with advanced urothelial cancer who were refractory to platinum-based chemotherapy or ...
https://www.onclive.com/view/ibrutinib-rituximab-combo-represents-effective-chemo-free-option-for-elderly-patients-with-mcl
Jan 14th, 2022 - The combination of ibrutinib (Imbruvica) and rituximab (Rituxan) produced a high overall response rate (ORR) and durable survival in elderly patients with mantle cell lymphoma (MCL), according to data from a phase 2 ENRICH trial (NCT0180567) publi...
https://www.medscape.com/viewarticle/954790
Jul 15th, 2021 - NEW YORK (Reuters Health) - Remdesivir treatment of lower respiratory infection in hospitalized patients with COVID-19 appears safe, even though some patients develop sinus bradycardia, a single-center prospective study from Italy suggests. "Cardi...
https://www.medpagetoday.com/cardiology/prevention/93347
Jun 29th, 2021 - The first report of potential thrombocytopenia with thrombosis after a COVID-19 mRNA vaccine: a 65-year-old man who died after receiving the second dose of the Moderna vaccine. (Annals of Internal Medicine) Two more case series describing myocardi...